![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1421-9913|72|1|35-38
ISSN: 0014-3022
Source: European Neurology, Vol.72, Iss.1, 2014-09, pp. : 35-38
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Is Interferon Effective and Safe for Relapsing-Remitting Multiple Sclerosis?
Neuroepidemiology, Vol. 21, Iss. 6, 2002-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Use of Natalizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis in Kuwait
Medical Principles and Practice, Vol. 22, Iss. 5, 2013-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
New Hypointense Lesions on MRI in Relapsing-Remitting Multiple Sclerosis Patients
European Neurology, Vol. 43, Iss. 4, 2000-05 ,pp. :